When combined with GLP-1 agonism, glucagon receptor activation increases energy expenditure through thermogenesis, enhances fat oxidation and breakdown, improves metabolic rate in ways that counteract the metabolic slowdown typically accompanying weight loss, and may provide additional central appetite regulation
In One Sentence: Retatrutide, also known as Triple G, is a once-weekly injectable medication currently being researched for weight loss and Type 2 diabetes, showing promising results in early studies by targeting multiple metabolic pathways involved in appetite control and fat metabolism
In this guide, well explore what to avoid, what to prioritize, and how to create a balanced plan that works with your treatmentnot against it
Neither peptide has been linked to a higher risk of low blood sugar in people without diabetes
Understanding GLP Receptor Research Learn how GLP receptor systems are discussed in research settings
Importantly, these studies compare outcomes with those of patients receiving other diabetes medications
